Trademark: 77977300
Word
RHINOBLOCK
Status
Dead
Status Code
606
Status Date
Monday, July 5, 2010
Serial Number
77977300
Mark Type
4000
Filing Date
Friday, December 21, 2007
Published for Opposition
Tuesday, September 8, 2009
Abandoned Date
Monday, July 5, 2010

Trademark Owner History
HERBALSCIENCE, INC. - Owner At Publication
HerbalScience Nutraceuticals, Inc. - Original Applicant

Classifications
1 Botanical extracts for use in the manufacture of nutraceuticals and pharmaceuticals; chemical extracts and active principals extracted from medicinal plants for use in the manufacture of pharmaceuticals; and botanical extracts in the manufacture of pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection
3 Herbal extracts sold as an integral ingredient in cosmetics; pre-moistened non-medicated personal hygiene wipes, namely, herpes relief wipes
5 Nutritional supplements; herbal products, namely, medicated skin and lip balms; herbal products for medical use, namely, medicated ointments, medicated oils, medicinal drinks, medicated syrups containing herbal extracts, bacterial poisons for medical purposes, and tinctures all for use in the treatment of strokes, infarcts and other cardiovascular and cerebrum diseases; herbal products for medicinal purposes, namely, herbal extracts for use as nutritional and dietary supplements; herbal products for medicinal purposes, namely, medicinal herbal extracts and medicated syrups containing herbal extracts; medicinal herb extracts; medicinal herbal extracts for medical purposes; plant extracts for medical or pharmaceutical purposes; yeast extracts for medical or pharmaceutical purposes; Medicinal botanical extracts used as component ingredients of pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tinctures, suppositories and filled ampule for injection used to treat skin ailments, for infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, inflammatory, cancer and related conditions; herbal products, namely, herbal powders being nutritional supplements; herbal products, namely, herbal powders in nutritional supplement drink mixes for nutritional purposes; herbal products, namely, herbal meal replacement powders for dietary and nutritional purposes; herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; oral preparations containing herbs or herbal extracts used to maintain health and for a wide variety of physical conditions; vitamin and mineral preparations intended for use as dietary supplements; vitamins; food supplements; pharmaceuticals and nutraceuticals, namely, vitamins and food supplements; pharmaceutical preparations, namely, appetite suppressants and lipid lowering agents; food for medically restricted diets; food supplements, namely, anti-oxidants; food for diabetics, infants and enteral feeding; botanical extracts for nutritional use, namely, for use as nutritional supplements; botanical extracts sold as an integral ingredient in nutraceuticals and pharmaceuticals for the treatment of, or relief of symptoms in, infectious diseases and adverse human health conditions, namely, infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, and/or inflammatory disorders and diseases, cancer and related conditions; anti-cough drops; cough drops; cough expectorants; cough lozenges; couch syrups; cough treatment preparations; cold sore treatment preparations; pharmaceutical antitussive-cold preparations; preparations for treating colds; analgesic preparations; analgesics; antipyretic analgesics; ibuprofen for use as an oral analgesic; multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; oral analgesics; topical analgesics; pharmaceutical preparations for the treatment and prevention of herpes; vaccines for the treatment and prevention of herpes; biological preparations for the treatment and prevention of herpes; pharmaceutical preparations for the treatment of herpes simplex infection; pharmaceutical capsules for the treatment of herpes simplex infection; homeopathic preparations for the treatment of herpes and cold sores; pharmaceutical preparations for the treatment of herpes viruses; medicated topical clear fluoride gel for the treatment of herpes virus during the physical manifestation of the virus; pharmaceutical preparations for the treatment of herpes simplex virus type I or type II or herpes zoster virus, not in intravenous form; plant based antivirals; over-the-counter topical antivirals; pharmaceutical preparation with antiviral or antimicrobial properties, or both, for use in the treatment of herpetic keratitis, conjunctivitis, HIV retinopathy, viral influenza "flu", herpes simplex virus 1, herpes simplex virus 2, varicella zoster virus "herpes zoster" "shingles", cytomegalovirus, viral parainfluenza, adenovirus, viral encephalitis, viral meningitis, arbovirus, arenavirus, picornavirus, coronavirus, syntialvirus, viral infections, common colds caused by viruses, cold sores, human immune deficiency virus "HIV", roseola infantum, human herpes IV; pharmaceutical preparations for the treatment of viral diseases and disorders, namely, herpes; pharmaceutical preparations for treating immune diseases induced by virus, namely, herpes zoster and AIDS
RHINO BLOCK

Trademark Events
Jul 6, 2010
Abandonment Notice Mailed - No Use Statement Filed
Jul 5, 2010
Abandonment - No Use Statement Filed
Dec 1, 2009
Noa Mailed - Sou Required From Applicant
Sep 8, 2009
Published For Opposition
Aug 19, 2009
Notice Of Publication
Aug 3, 2009
Law Office Publication Review Completed
Aug 3, 2009
Approved For Pub - Principal Register
Jul 28, 2009
Amendment From Applicant Entered
Jul 28, 2009
Correspondence Received In Law Office
Jul 27, 2009
Paper Received
Jul 20, 2009
Notification Of Priority Action E-Mailed
Jul 20, 2009
Priority Action E-Mailed
Jul 20, 2009
Priority Action Written
Jun 25, 2009
Amendment From Applicant Entered
Jun 25, 2009
Correspondence Received In Law Office
Jun 25, 2009
Paper Received
Jun 12, 2009
Examiner's Amendment Entered
Jun 11, 2009
Notification Of Examiners Amendment E-Mailed
Jun 11, 2009
Examiners Amendment E-Mailed
Jun 11, 2009
Examiners Amendment -Written
Jun 2, 2009
Notice Of Pseudo Mark Mailed
Jun 1, 2009
Divisional Processing Complete
Apr 21, 2009
Divisional Request Received
May 19, 2009
Teas/Email Correspondence Entered
May 19, 2009
Correspondence Received In Law Office
May 18, 2009
Teas Request For Reconsideration Received
May 18, 2009
Ex Parte Appeal-Instituted
May 18, 2009
Jurisdiction Restored To Examining Attorney
May 18, 2009
Exparte Appeal Received At Ttab
Apr 21, 2009
Request To Divide Untimely, Refused, Or Withdrawn
Apr 13, 2009
Case Assigned To Intent To Use Paralegal
Apr 9, 2009
Paper Received
Apr 1, 2009
Automatic Update Of Assignment Of Ownership
Nov 17, 2008
Notification Of Final Refusal Emailed
Nov 17, 2008
Final Refusal E-Mailed
Nov 17, 2008
Final Refusal Written
Oct 27, 2008
Amendment From Applicant Entered
Oct 27, 2008
Correspondence Received In Law Office
Oct 22, 2008
Assigned To Lie
Oct 7, 2008
Paper Received
Apr 3, 2008
Notification Of Non-Final Action E-Mailed
Apr 3, 2008
Non-Final Action E-Mailed
Apr 3, 2008
Non-Final Action Written
Mar 27, 2008
Assigned To Examiner
Dec 29, 2007
Notice Of Pseudo Mark Mailed
Dec 28, 2007
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24